Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Intra-nasal Naloxone for Treatment of Impaired Awareness of Hypoglycemia

NCT02700048 is registered in ClinicalTrials.gov with University of Minnesota as lead sponsor.

NCT NCT02700048
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02700048 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Intra-nasal Naloxone for Treatment of Impaired Awareness of Hypoglycemia
Lead sponsor
University of Minnesota
Phase
Phase 1/2
Overall status
Terminated
Start date
June 30, 2016
Completion date
July 31, 2021
Enrollment
11 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hypoglycemia unawareness, type 1 diabetes